Imaging integrin alpha-v-beta-3 expression in tumors with an 18F-labeled dimeric RGD peptide

Contrast Media and Molecular Imaging

Volumn 8, Issue 3, 2013, Pages 238-245

  Dijkgraaf, Ingrid ^a   Terry, Samantha Y A ^b   Mcbride, William J ^c   Goldenberg, David M ^c   Laverman, Peter ^b   Franssen, Gerben M ^b   Oyen, Wim J G ^b   Boerman, Otto C ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c IMMUNOMEDICS INC   (United States)

Author keywords

Aluminum fluoride; Integrin alpha v beta 3; NODAGA; PET; Radiofluorination; RGD

Indexed keywords

NODAGA ARGINYLGLYCYLASPARTIC ACID F 18; NODAGA ARGINYLGLYCYLASPARTIC ACID GA 68; NODAGA ARGINYLGLYCYLASPARTIC ACID IN 111; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; DRUG UPTAKE; FEMALE; IN VIVO STUDY; KIDNEY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; DIMERIZATION; FEMALE; FLUORINE RADIOISOTOPES; GENE EXPRESSION REGULATION, NEOPLASTIC; INTEGRIN ALPHAVBETA3; ISOTOPE LABELING; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED C57BL; MICE, NUDE; MOLECULAR IMAGING; NEOPLASMS, EXPERIMENTAL; OLIGOPEPTIDES; ORGAN SPECIFICITY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84876785612     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.1523     Document Type: Article

References (40)

1. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. Science 1987; 238(4826): 491-497.
2. Haubner R, Finsinger D, Kessler H. Stereoisomeric peptide libraries and peptidomimetics for designing selective inhibitors of the alpha(V)beta(3) integrin for a new cancer therapy. Angew Chem Int Edn 1997; 36(13-14): 1375-1389.
3. 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res 2001; 61(5): 1781-1785.
4. 18F-galacto-RGD in cancer patients. J Nucl Med 2005; 46(8): 1333-1341.
5. Haubner R, Weber WA, Beer AJ, Vabuliene E, Reim D, Sarbia M, Becker KF, Goebel M, Hein R, Wester HJ, Kessler H, Schwaiger M. Noninvasive visualization of the activated alpha v beta 3 integrin in cancer patients by positron emission tomography and [F-18]Galacto-RGD. PLoS Med 2005; 2(3): 244-252.
6. Morrison MS, Ricketts SA, Barnett J, Cuthbertson A, Tessier J, Wedge SR. Use of a novel Arg-Gly-Asp Radioligand, (18)F-AH111585, to determine changes in tumor vascularity after antitumor therapy. J Nucl Med 2009; 50(1): 116-122.
7. McParland BJ, Miller MP, Spinks TJ, Kenny LM, Osman S, Khela MK, Aboagye E, Coombes RC, Hui AM, Cohen PS. The biodistribution and radiation dosimetry of the Arg-Gly-Asp Peptide F-18-AH111585 in healthy volunteers. J Nucl Med 2008; 49(10): 1664-1667.
8. Kenny LM, Coombes RC, Oulie I, Contractor KB, Miller M, Spinks TJ, McParland B, Cohen PS, Hui AM, Palmieri C, Osman S, Glaser M, Turton D, At-Nahhas A, Aboagye EO. Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand F-18-AH111585 in breast cancer patients. J Nucl Med 2008; 49(6): 879-886.
9. Visser EP, Disselhorst JA, Brom M, Laverman P, Gotthardt M, Oyen WJG, Boerman OC. Spatial resolution and sensitivity of the Inveon small-animal PET scanner. J Nucl Med 2009; 50(1): 139-147.
10. Poethko T, Schottelius M, Thumshirn G, Hersel U, Herz M, Henriksen G, Kessler H, Schwaiger M, Wester HJ. Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs. J Nucl Med 2004; 45(5): 892-902.
11. Haubner R, Wester HJ, Burkhart F, Senekowitsch-Schmidtke R, Weber W, Goodman SL, Kessler H, Schwaiger M. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med 2001; 42(2): 326-336.
12. Schottelius M, Wester HJ, Reubi JC, Senekowitsch-Schmidtke R, Schwaiger M. Improvement of pharmacokinetics of radioiodinated Tyr(3)-octreotide by conjugation with carbohydrates. Bioconjug Chem 2002; 13(5): 1021-1030.
13. Wester HJ, Schottelius M, Scheidhauer K, Reubi JC, Wolf I, Schwaiger M. Comparison of radioiodinated TOC, TOCA and Mtr-TOCA: the effect of carbohydration on the pharmacokinetics. Eur J Nucl Med Mol Imag 2002; 29(1): 28-38.
14. Schottelius M, Poethko T, Herz M, Reubi JC, Kessler H, Schwaiger M, Wester HJ. First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography. Clin Cancer Res 2004; 10(11): 3593-3606.
15. Hultsch C, Schottelius M, Auernheimer J, Alke A, Wester HJ. (18)F-Fluoroglucosylation of peptides, exemplified on cyclo(RGDfK). Eur J Nucl Med Mol Imaging 2009; 36(9): 1469-1474.
16. 18F]FDG. Bioconjug Chem 2009; 20(3): 432-436.
17. Li ZB, Wu Z, Chen K, Chin FT, Chen X. Click chemistry for (18)F-labeling of RGD peptides and microPET imaging of tumor integrin alphavbeta3 expression. Bioconjug Chem 2007; 18(6): 1987-1994.
18. Schirrmacher E, Wangler B, Cypryk M, Bradtmoller G, Schafer M, Eisenhut M, Jurkschat K, Schirrmacher R. Synthesis of p-(di-tert-butyl[(18)F]fluorosilyl)benzaldehyde ([(18)F]SiFA-A) with high specific activity by isotopic exchange: a convenient labeling synthon for the (18)F-labeling of N-amino-oxy derivatized peptides. Bioconjug Chem 2007; 18(6): 2085-2089.
19. Schirrmacher R, Wangler C, Schirrmacher E. Recent developments and trends in F-18-radiochemistry: syntheses and applications. Mini-Rev Org Chem 2007; 4(4): 317-329.
20. 18F-radiolabeling of peptides for PET imaging. Angew Chem Int Edn Engl 2008; 47(26): 4922-4925.
21. 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks. Bioconjug Chem 2008; 19(9): 1871-1879.
22. Iovkova L, Wangler B, Schirrmacher E, Schirrmacher R, Quandt G, Boening G, Schurmann M, Jurkschat K. Para-functionalized aryl-di-tert-butylfluorosilanes as potential labeling synthons for (18)F radiopharmaceuticals. Chemistry 2009; 15(9): 2140-2147.
23. 18F]SiFA-isothiocyanate: a new highly effective radioactive labeling agent for lysine-containing proteins. Chem Biochem 2009; 10(8): 1321-1324.
24. 18F]FA-SH) labeled rat serum albumin for blood pool imaging with PET. Bioconjug Chem 2009; 20(2): 317-321.
25. 18F]-labeled aryltrifluoroborate radiotracers: in vivo positron emission tomography imaging of stable aryltrifluoroborate clearance in mice. J Am Chem Soc 2008; 130(36): 12045-12055.
26. Studenov AR, Adam MJ, Wilson JS, Ruth TJ. New radiolabelling chemistry: synthesis of phosphorus-[F-18]fluorine compounds. J Labelled Compd Rad 2005; 48(7): 497-500.
27. 18F radiolabeling for PET. J Nucl Med 2009; 50(6): 991-998.
28. Laverman P, McBride WJ, Sharkey RM, Eek A, Joosten L, Oyen WJ, Goldenberg DM, Boerman OC. A novel facile method of labeling octreotide with (18)F-fluorine. J Nucl Med 2010; 51(3): 454-461.
29. 68Ga]NODAGA-RGD for imaging alphavbeta3 integrin expression. Eur J Nucl Med Mol Imag 2011; 38(7): 1303-1312.
30. 18F labeling of peptides with a fluoride-aluminum-chelate complex. Bioconjug Chem 2010; 21(7): 1331-1340.
31. 18F-AlF-NOTA-PRGD2. Eur J Nucl Med Mol Imaging 2012; 39(4): 683-692.
32. de Sa A, Prata MIM, Geraldes CFGC, Andre JP. Triaza-based amphiphilic chelators: Synthetic route, in vitro characterization and in vivo studies of their Ga(III) and Al(III) chelates. J Inorg Biochem 2010; 104(10): 1051-1062.
33. D'Souza CA, McBride WJ, Sharkey RM, Todaro LJ, Goldenberg DM. High-yielding aqueous (18)F-labeling of peptides via Al(18)F chelation. Bioconjug Chem 2011; 22(9): 1793-1803.
34. 111In-labelled DOTA-RGD peptides for imaging of alphavbeta3 integrin expression. Eur J Nucl Med Mol Imaging 2008; 35(8): 1507-1515.
35. Liu S, Liu H, Jiang H, Xu Y, Zhang H, Cheng Z. One-step radiosynthesis of (1)F-AlF-NOTA-RGD for tumor angiogenesis PET imaging. Eur J Nucl Med Mol Imaging 2011; 38(9): 1732-1741.
36. Lang LX, Li WH, Guo N, Ma Y, Zhu L, Kiesewetter DO, Shen BZ, Niu G, Chen XY. Comparison study of [(18)F]FAI-NOTA-PRGD2, [(18)F]FPPRGD2, and [(68)Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in Mice. Bioconjug Chem 2011; 22(12): 2415-2422.
37. Max R, Gerritsen RR, Nooijen PT, Goodman SL, Sutter A, Keilholz U, Ruiter DJ, De Waal RM. Immunohistochemical analysis of integrin alpha vbeta3 expression on tumor-associated vessels of human carcinomas. Int J Cancer 1997; 71(3): 320-324.
38. Laverman P, D'Souza CA, Eek A, McBride WJ, Sharkey RM, Oyen WJ, Goldenberg DM, Boerman OC. Optimized labeling of NOTA-conjugated octreotide with F-18. Tumour Biol 2012; 33(2): 427-434.
39. Dijkgraaf I, Kruijtzer JA, Liu S, Soede AC, Oyen WJ, Corstens FH, Liskamp RM, Boerman OC. Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides. Eur J Nucl Med Mol Imaging 2007; 34(2): 267-273.
40. van der Have F, Vastenhouw B, Ramakers RM, Branderhorst W, Krah JO, Ji CG, Staelens SG, Beekman FJ. U-SPECT-II: an ultra-high-resolution device for molecular small-animal imaging. J Nucl Med 2009; 50(4): 599-605.